Neotherix has been selected to present at the next Oxford Investment Opportunity Network (OION) Investment Meeting on Tuesday 20 September 2011 at the Saïd Business School, University of Oxford.
OION is a business angel network that links investor members to high growth technology (particularly MedTech) companies seeking business and product development funds. Its members also include venture capital firms, funds, and corporate venturers. In the last three years OION has helped over 40 companies to secure more than £27m in funding.
Dr Mike Raxworthy, the company's founder and CEO, will be presenting on Neotherix to an invited audience of investors. Mikes presentation will focus mainly on EktoTherix regenerative tissue scaffold for acute wound repair but will also cover opportunities arising from pipeline projects. Also attending the event will be Dr Rod Adams, Chairman of Neotherix.
Link to the OION web site .